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This study assesses the extent to which the strength of a recommendation in a World Health 
Organization (WHO) guideline affects uptake of the recommendation in national guidelines. 
Study Design and Setting 
The uptake of recommendations included in HIV and TB guidelines issued by WHO from 2009 to 
2013 was assessed across guidelines from 20 low- and middle-income countries in Africa and 
Southeast Asia. Associations between characteristics of recommendations (strength, quality of the 
evidence, type) and uptake were assessed using logistic regression. 
Results 
Eight WHO guidelines consisting of 109 strong recommendations and 49 conditional 
recommendations were included, and uptake assessed across 44 national guidelines (1,255 
recommendations) from 20 countries. Uptake of WHO recommendations in national guidelines was 
82% for strong recommendations and 61% for conditional recommendations. The odds of uptake 
comparing strong recommendations and conditional recommendations was 1.9 (95% confidence 
interval: 1.4, 2.7), after adjustment for quality of evidence. Higher levels of evidence quality were 
associated with greater uptake, independent of recommendation strength. 
Conclusion 
Guideline developers should be confident that conditional recommendations are frequently adopted. 
The fact that strong recommendations are more frequently adopted than conditional recommendations 
underscores the importance of ensuring that such recommendations are justified. 
Key findings 
Uptake of World Health Organization recommendations in national guidelines is high and associated 
with strength of recommendation and evidence quality. A higher level of evidence quality was 
associated with greater uptake of the recommendation, independent of strength. 
What this adds to what was known? 
Conditional recommendations are frequently adopted, although less frequently than strong 
recommendations. 
What is the implication and what should change now? 
Guideline developers should be confident that conditional recommendations are frequently adopted. 
The fact that strong recommendations are more frequently adopted than conditional recommendations 
underscores the importance of ensuring that such recommendations are justified. 
1. Introduction 
Guidelines issued by the World Health Organization (WHO) aim to help policy makers, health care 
providers, and patients make evidence-informed decisions [1]. Although global in intent, WHO 
guidelines are primarily focused on the needs and resources of low- and middle-income countries, 
where they are often used to develop national guidelines. The potential impact of WHO 
recommendations is far reaching, including influencing individual clinician practice, health service 
organization, the procurement policies of international donors, and potentially the global demand for 
health technologies. 
WHO adopted the Grading of Recommendations Assessment, Development, and Evaluation 
(GRADE) [2] system in January 2009 to support the formulation of evidence-based recommendations. 
Since that time, there has been a steady increase in the number of recommendations issued by WHO 
that are based on the GRADE approach [3], [4] and [5]. 
According to GRADE, the strength of the recommendation is designated as either “strong” or “weak” 
(commonly termed “conditional” in WHO guidelines), with strong recommendations generally based 
on high-quality evidence from randomized controlled trials, except in certain circumstances [6]. If the 
GRADE framework is followed without any bias on the part of guideline developers, then it would be 
reasonable to expect that conditional recommendations would be adopted in fewer national guidelines 
than strong recommendations, as their scope is by definition more limited. However, there has been 
no assessment to date of the extent to which WHO recommendations are adopted in national policy, 
nor whether recommendation characteristics (ie, strength; quality of supporting evidence) influence 
uptake in national guidelines. Such an assessment would provide evidence to inform guideline 
development groups about the potential influence of recommendation strength on uptake in national 
guidelines. 
This study aimed to assess the association between the strength of WHO recommendations and uptake 
in national policy. 
2. Methods 
2.1. Data sources 
To assess the relationship between the characteristics of WHO recommendations and their uptake in 
national guidelines, a database of both WHO and national guidelines was constructed. HIV and TB 
guidelines had previously been found to show a high adherence to the GRADE process [4], and 
exploratory Web searches found a number of repositories that could serve as sources for national 
guidelines. All HIV and TB guidelines published by WHO from January 2008 to December 2013 
were retrieved from a WHO repository (http://who.int/publications/guidelines/en/) and cross-checked 
with experts at WHO to check that no guidelines were missed. To be included, WHO guidelines 
needed to have been developed according to the GRADE approach. 
Four principle online resources were used to identify national guidelines: The USAID AIDSTAR-One 
National Treatment Database for HIV [7], AIDSspace Guideline Repository [8], the WHO Database 
of National HIV and TB guidelines 2005–2011 [9], and the UNAIDS Global Database of HIV/AIDS 
guidelines [10]. National guidelines had to fulfill the following criteria: published in English, low- or 
middle-income setting as determined by World Bank income grouping [11], and published between 
January 1, 2009 (when WHO first adopted the GRADE process), and December 31, 2013. 
National guidelines were tabulated, assigned unique identification codes, and classified as follows: 
adult and adolescent HIV care, pediatric HIV care, prevention of mother to child transmission, HIV 
opportunistic infection care, HIV/TB coinfection, and TB management. 
To be included, national guidelines had to be published after a corresponding WHO guideline to 
ensure that national guideline developers would have had access to the relevant WHO 
recommendations when formulating policy. Where this was uncertain (eg, when WHO and national 
guidelines were published within the same year), national guidelines were only included if they 
specifically referenced the corresponding WHO guideline. 
2.2. Data management 
Recommendations were extracted from WHO guidelines by one reviewer (S.M.U.N.), then tabulated, 
and coded in MS Excel (Microsoft, Redmond WA, USA). The following characteristics were 
recorded for each recommendation: strength of recommendation (strong or conditional); quality of 
evidence (high, moderate, low, or very low); domain (HIV, HIV/TB, or TB); target population or 
condition (general, adults and adolescents, maternal health, and pediatrics); and type of intervention 
(prevention, diagnostic test, and treatment). Quality of evidence in the GRADE paradigm refers to the 
confidence or uncertainty in the estimates of effect [12]. 
For each national guideline, corresponding WHO recommendations were sought by examining the 
full text of each guideline and searching for key words. Each national recommendation was 
considered to adhere to a specific WHO recommendation only if the national policy adhered to all the 
key features of the corresponding WHO recommendation. Nonadherence was determined when the 
national recommendation explicitly contradicted the corresponding WHO recommendation, reflected 
some but not all its key features, or adapted the WHO recommendation beyond its intended scope. 
2.3. Statistical analysis 
The association between the strength of a recommendation and its uptake in national guidelines was 
explored using descriptive statistics with differences assessed by the χ2 test. Univariate and 
multivariate logistic regression analyses were used to determine the strength of any association (the 
dependent variable) after controlling for the following variables that were defined a priori: quality of 
the evidence, type of guideline, and type of recommendation. The potential for clustering by country, 
guideline type, and intervention type was assessed by Spearman's rank correlation coefficient (ρ). All 
reported P-values are exacted and two tailed, and for each analysis, a P-value less than 0.05 was 
considered significant. All analyses were carried out in Stata, version 12 (StataCorp LP, TX, USA). 
The full data set is available on request from the corresponding author (N.F.). 
3. Results 
3.1. Characteristics of guidelines and recommendations 
Eight eligible WHO guidelines were included in this study, all published between 2009 and 2012 [13], 
[14], [15], [16], [17], [18], [19] and [20]. 
Five of these focused on HIV care, two focused on TB care, and one focused on HIV/TB 
comanagement. The total number of recommendations in these eight guidelines was 158, of which 
109 were strong recommendations and 49 were conditional recommendations. The distribution of 
these recommendations is summarized in Table 1. 
Table 1.  













High quality 27 138 0 0 
Moderate quality 37 327 1 2 
Low quality 37 505 27 174 
Very low quality 8 283 21 207 
Abbreviation: WHO, World Health Organization. 
N.B. data are the number of recommendations. 
The number of national guidelines that met the inclusion criteria was 44, containing 1,255 
recommendations. Twenty countries were represented: nine lower income, seven lower-middle 
income, and four upper-middle income (Table 2). 
Table 2.  
Summary of national guidelines 




Africa Ethiopia Kenya, Malawi, Tanzania, Uganda, Zimbabwe 12 
Asia Bangladesh, Cambodia, Nepal 7 
Lower-middle 
income 
Africa Ghana, Lesotho, Nigeria, Zambia 9 
Asia India, Sri Lanka, Vietnam 7 
Upper-middle 
income 
Africa Botswana, Namibia, South Africa 8 
Asia Malaysia 1 
Total 20 44 
a 
As defined by the World Bank. 
The 158 WHO recommendations were compared with the 1,255 recommendations reported in 
national guidelines. Overall, 76% of WHO recommendations were taken up by national guidelines: 
81.9% (n = 715) of strong recommendations and 61.2% (n = 234) of conditional recommendations in 
WHO guidelines were adopted as national policy recommendations (P < 0.01). None of the national 
guidelines reported the strength of the WHO recommendations or the quality of the body of evidence. 
In univariate logistic regression, strong recommendations were found to be almost three times more 
likely to be taken up by national guidelines compared with recommendations that were conditional 
[odds ratio (OR) 2.9; 95% confidence interval (CI): 2.2, 3.8]. This association remained statistically 
significant in multivariate logistic regression after controlling for the quality of the evidence 
supporting a recommendation (OR 1.9; 95% CI: 1.4, 2.7). 
Among strong recommendations, the uptake of a recommendation varied according to the quality of 
the evidence supporting the recommendation. Compared with strong recommendations based on low- 
or very low-quality evidence, there was a statistically significantly greater odds of uptake for 
recommendations based on high or moderate quality evidence (OR 2.0; 95% CI: 1.4, 2.8). 
There was no statistically significant difference in uptake between a strong recommendation based on 
very low quality of evidence and conditional recommendations in general (P = 0.3). Nor was there a 
statistically significant difference in uptake according World Bank income bracket or among 
population subgroups (all P > 0.05). 
There was weak clustering of strength of recommendation by guideline (ρ 0.19, P ≤ 0.01) and by 
country (ρ 0.11, P ≤ 0.01) and even weaker clustering by intervention (ρ 0.01, P ≤ 0.03). However, 
these associations were not considered strong enough to significantly influence the main results. 
4. Discussion 
This study assessed the uptake of 158 recommendations contained within eight WHO guidelines by 
national guidelines from 20 countries and found that overall 76% of WHO recommendations were 
taken up by national guidelines. Strong recommendations were, on average, adopted 82% of the time, 
whereas conditional recommendations were taken up 61% of the time. After adjusting for quality of 
the evidence, there was a near twofold higher odds of uptake of strong recommendations compared 
with conditional recommendations. For strong recommendations, higher levels of quality of the 
evidence were associated with increased uptake in national guidelines; strong recommendations based 
on very low evidence quality were not more likely to be adopted than were conditional 
recommendations. 
A recent evaluation of WHO guidelines reported that over half of strong recommendations were based 
on low or very low evidence quality [21]. The perception that conditional recommendations are 
infrequently adopted has been put forward as an explanation for why guideline developers may opt to 
make a recommendation strong despite low-quality evidence. Our study challenges this assumption: 
conditional recommendations are often taken up in national guidelines, although appropriately less 
frequently than are strong recommendations. These results should help to assuage any doubts within 
guideline development groups regarding the utility of conditional recommendations. The high average 
uptake of WHO recommendations, the disparity in uptake between strong and conditional 
recommendations, and the relatively lower uptake of strong recommendations based on weak 
evidence indicate that national policy makers are interpreting GRADE-based WHO guidelines 
appropriately. 
We found that independent of the strength of recommendations, the quality of the body of evidence 
was also a factor related to uptake of national recommendations. This finding has important 
implications for WHO guideline development and presentation. The GRADE assessment of the 
quality of evidence must be carefully reasoned and presented in an explicit and transparent manner, 
given that end users take this assessment into consideration. The quality of the evidence for critical 
outcomes could be presented in each guideline's executive summary, and a summary of the key 
domains leading to the quality assessment should be provided in the text of the guideline and not 
buried in appendices. Of note, none of the national guidelines reported the strength of 
recommendation or the quality of the body of evidence, which has been put forward as a key criterion 
for trustworthiness by the US Institute of Medicine [22]. 
Finally, our study suggests that any disparity between recommendation strength and evidence quality 
should be carefully considered, given that strong recommendations based on very low evidence 
quality appear to be adopted no more frequently than conditional recommendations overall. 
This study has a number of strengths, including examination of an extensive data set across a range of 
recommendation types and countries. A careful assessment was carried out to ensure that 
recommendations in national guidelines were preceded by, and corresponded with, the most recent 
relevant recommendations issued by WHO. Our study is limited, however, as we were limited in the 
number of national guidelines that we were able to retrieve, and the ones that we did identify may not 
be representative of the entire cohort of relevant guidelines. In addition, we examined only two 
diseases (HIV and TB), and the applicability of our findings to other conditions or interventions is 
unclear. We cannot rule out the possibility that some of the national guidelines may not have been 
based on WHO guidelines, although we consider this unlikely as most guidelines made explicit 
reference to WHO guidelines, and a criterion for inclusion in this study was that the national guideline 
was published after the corresponding WHO guideline. Last, although this assessment provides an 
insight into uptake of recommendations of national guidelines, no inferences can be drawn regarding 
the implementation of these recommendations in practice. 
The results of this study represent a first step in the analysis of the uptake of WHO recommendations 
at the country level based on the strength of the recommendation. Further research with an expanded 
data set would better quantify the relationship between recommendation characteristics and uptake in 
national guidelines, including non-English language guidelines and guidelines in other topic areas. 
Such quantitative assessments could be complemented with qualitative research to understand the 
priorities and perceptions of policy makers. 
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